Can a glucose monitor boost diabetes education for newly diagnosed patients?
NCT ID NCT05676593
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether using a Freestyle Libre 2 continuous glucose monitor for 28 days, along with standard therapeutic education, helps people recently diagnosed with type 2 diabetes improve their blood sugar control. The trial enrolled 27 adults diagnosed within the past year. The main goal was to see if the monitor led to better HbA1c levels after 3 months compared to education alone.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Freestyle Libre 2 (continuous glucose monitor)
- What this could lead to
- If successful, this could show that using a continuous glucose monitor alongside standard education helps people with newly diagnosed type 2 diabetes better manage their blood sugar.
- What could go wrong
- This was a small, early study (27 participants) that was terminated, so results may be limited. The device only measures glucose and does not treat the disease directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
27 people
The number who actually took part.
- Started
-
May 2023
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * recently diagnosed diabete mellitus (\<1 an) treated by non medical therapeutics and/or metformine * \> 18 years old * initial glycated hemoglobin between 7 and 8.5% Exclusion Criteria: * Person whose physical and/or psychological health is severely impaired * Person deprived of his rights, person under guardianship or curatorship * Person deprived of liberty (by judicial or administrative decision) * Person who does not speak the French language * Absence of affiliation to/Not beneficiary of a Social Security scheme * Absence of written informed consent to participate in the study * Unable to understand the nature, purpose and methodology of the study * Bariatric surgery planned within 6 months of inclusion
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Endocrinology are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UHM Montpellier
Montpellier, 34090, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can mindfulness and yoga rewire diabetes habits?
- Can a vegan diet delivered online help people with type 2 diabetes?
- Tiny horses, big lessons: can ponies help kids tame diabetes?
- Gut microbes in pregnancy and infancy: a window into lifelong health?
- A blood test at 50 could flag your risk of five diseases. can an app stop them?
- Chatbot coach takes aim at diabetes risk after pregnancy